Emerging Markets Compound Stagnation In Developed Economies
This article was originally published in The Tan Sheet
Executive Summary
The rapid growth of emerging markets – key regions for many OTC firms – is a major contributor to the industrialized world’s economic stagnation, an HSBC analyst says. Emerging market growth hinders recovery in developed markets by driving up commodity and oil costs, breaking the link in the traditional boom-bust economic cycle.
You may also be interested in...
Multinationals Turn To Smaller Markets To Avoid BRIC Restrictions
Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.
Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. managed to sell its growing nutritional business to French food giant Group Danone for a reported $354 million
Reckitt Continues Asian Push With $724M Paras Purchase
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.